RETA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 26.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Reata Pharmaceuticals Insider Trading History Chart

Reata Pharmaceuticals Share Price & Price History

^$172.36

▲ +0.04 (0.02%)

As of 09/26/2023 09:00 PM ET

Reata Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/14/2023	Andrea Loewen	SVP	Sell	3,175	$172.03	$546,195.25	28,416
7/28/2023	Dawn Carter Bir	Insider	Sell	40,000	$164.54	$6,581,600.00	35,010
7/28/2023	Manmeet Singh Soni	CFO	Sell	75,000	$164.62	$12,346,500.00	64,376
7/28/2023	Shamim Ruff	Director	Sell	8,235	$164.53	$1,354,904.55	7,359
6/14/2023	Bhaskar Anand	CAO	Sell	2,343	$102.11	$239,243.73	24,898
6/13/2023	Manmeet Singh Soni	CFO	Sell	78,085	$102.89	$8,034,165.65	58,376
5/15/2023	Andrea Loewen	SVP	Sell	103	$84.71	$8,725.13	31,904
5/15/2023	Manmeet Singh Soni	CFO	Sell	21,507	$84.56	$1,818,631.92	116,797
5/15/2023	Michael D. Wortley	Insider	Sell	894	$84.81	$75,820.14	47,198
5/12/2023	Andrea Loewen	SVP	Sell	6,750	$86.26	$582,255.00	32,007
3/10/2023	Shamim Ruff	Director	Sell	5,740	$83.73	$480,610.20	5,223
3/7/2023	Andrea Loewen	SVP	Sell	19,036	$83.43	$1,588,173.48	38,757
3/7/2023	Bhaskar Anand	CAO	Sell	165	$84.58	$13,955.70	26,765
3/6/2023	Dawn Carter Bir	Insider	Sell	54,954	$89.56	$4,921,680.24	41,925
3/3/2023	Bhaskar Anand	CAO	Sell	820	$87.47	$71,725.40	26,930
3/3/2023	Dawn Carter Bir	Insider	Sell	2,166	$88.25	$191,149.50	48,509
3/3/2023	Manmeet Singh Soni	CFO	Sell	3,587	$87.97	$315,548.39	88,926
3/2/2023	Samina Khan	SVP	Sell	25,000	$84.88	$2,122,000.00	46,905

See Full Table

SEC Filings (Institutional Ownership Changes) for Reata Pharmaceuticals (NASDAQ:RETA)

Institutional Buying and Selling by Quarter

Reata Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/21/2023	Barclays PLC	79,034	$8.06M	0.0%	+371.7%	0.207%
8/24/2023	Perceptive Advisors LLC	670,206	$68.33M	2.0%	-69.1%	1.757%
8/21/2023	VisionPoint Advisory Group LLC	403	$41K	0.0%	N/A	0.001%
8/21/2023	Affinity Asset Advisors LLC	29,105	$2.97M	1.0%	N/A	0.076%
8/15/2023	Silverarc Capital Management LLC	12,500	$1.27M	0.4%	N/A	0.033%
8/15/2023	Suvretta Capital Management LLC	108,832	$11.10M	0.6%	+620.7%	0.290%
8/15/2023	Boxer Capital LLC	1,430,004	$145.80M	6.8%	+16.3%	3.808%
8/14/2023	NinePointTwo Capital LLC	2,868	$0.29M	0.1%	N/A	0.008%
8/14/2023	Tolleson Wealth Management Inc.	33,250	$3.39M	0.8%	-17.4%	0.089%
8/14/2023	Schonfeld Strategic Advisors LLC	114,520	$11.68M	0.1%	+108.4%	0.305%
8/14/2023	UniSuper Management Pty Ltd	29,324	$2.99M	0.0%	N/A	0.078%
8/14/2023	Driehaus Capital Management LLC	94,945	$9.68M	0.1%	N/A	0.253%
8/14/2023	Prelude Capital Management LLC	10,550	$1.08M	0.1%	N/A	0.028%
8/14/2023	Wallace Capital Management Inc.	22,175	$2.26M	0.3%	N/A	0.059%
8/11/2023	Nan Fung Group Holdings Ltd	3,300	$0.34M	0.2%	N/A	0.009%
8/11/2023	Ameritas Investment Partners Inc.	2,360	$0.24M	0.0%	+9.6%	0.006%
8/11/2023	Harvest Investment Services LLC	18,655	$1.90M	1.1%	+81.2%	0.050%
8/11/2023	Biondo Investment Advisors LLC	12,750	$1.30M	0.2%	+259.2%	0.034%
8/11/2023	Sectoral Asset Management Inc.	47,500	$4.84M	0.8%	+90.0%	0.126%
8/11/2023	Atika Capital Management LLC	22,000	$2.24M	0.2%	N/A	0.059%
8/11/2023	Geode Capital Management LLC	593,430	$60.51M	0.0%	+8.0%	1.580%
8/11/2023	Sei Investments Co.	41,890	$4.27M	0.0%	+238.9%	0.112%
8/11/2023	JPMorgan Chase & Co.	206,223	$21.03M	0.0%	-52.4%	0.549%
8/11/2023	PNC Financial Services Group Inc.	4,156	$0.42M	0.0%	+1.5%	0.011%
8/11/2023	Northern Trust Corp	287,968	$29.36M	0.0%	+1.8%	0.767%
8/10/2023	MetLife Investment Management LLC	15,065	$1.54M	0.0%	+4.3%	0.040%
8/10/2023	Metropolitan Life Insurance Co NY	1,561	$0.16M	0.0%	+4.4%	0.004%
8/10/2023	ProShare Advisors LLC	5,855	$0.60M	0.0%	+6.9%	0.016%
8/10/2023	Profund Advisors LLC	7,007	$0.71M	0.0%	+52.1%	0.019%
8/10/2023	Edgestream Partners L.P.	3,671	$0.37M	0.0%	-70.3%	0.010%
8/10/2023	US Bancorp DE	8,875	$0.91M	0.0%	-8.0%	0.024%
8/10/2023	Charles Schwab Investment Management Inc.	216,012	$22.03M	0.0%	+4.4%	0.575%
8/10/2023	Tekla Capital Management LLC	34,250	$3.49M	0.1%	+91.9%	0.091%
8/10/2023	Citigroup Inc.	16,422	$1.67M	0.0%	-71.7%	0.044%
8/9/2023	TD Asset Management Inc	6,600	$0.67M	0.0%	-25.6%	0.018%
8/9/2023	Swiss National Bank	52,400	$5.34M	0.0%	-10.0%	0.140%
8/9/2023	TimesSquare Capital Management LLC	344,580	$35.13M	0.5%	+10,034.7%	0.918%
8/8/2023	Rhumbline Advisers	48,033	$4.90M	0.0%	+18.9%	0.128%
8/8/2023	Commerce Bank	6,000	$0.61M	0.0%	N/A	0.016%
8/7/2023	Principal Financial Group Inc.	7,051	$0.72M	0.0%	-11.8%	0.019%
8/4/2023	American International Group Inc.	13,757	$1.40M	0.0%	+3.1%	0.037%
8/3/2023	Headlands Technologies LLC	2,602	$0.27M	0.1%	N/A	0.007%
8/3/2023	Barclays PLC	79,034	$8.06M	0.0%	+371.7%	0.210%
8/3/2023	Bank of New York Mellon Corp	132,343	$13.49M	0.0%	+30.2%	0.352%
8/2/2023	Bank of Montreal Can	22,595	$2.31M	0.0%	N/A	0.060%
8/2/2023	State of New Jersey Common Pension Fund D	26,606	$2.71M	0.0%	N/A	0.071%
8/2/2023	Handelsbanken Fonder AB	5,732	$0.58M	0.0%	-30.4%	0.015%
8/2/2023	Sigma Planning Corp	3,775	$0.39M	0.0%	-40.3%	0.010%
8/1/2023	Arizona State Retirement System	6,762	$0.69M	0.0%	-13.5%	0.018%
7/31/2023	Strs Ohio	500	$50K	0.0%	N/A	0.001%
7/28/2023	Braun Stacey Associates Inc.	164,775	$16.80M	0.8%	-47.0%	0.439%
7/28/2023	Moody Aldrich Partners LLC	51,533	$5.25M	1.0%	+4.0%	0.137%
7/27/2023	Victory Capital Management Inc.	211,931	$21.61M	0.0%	+31.1%	0.564%
7/24/2023	Allspring Global Investments Holdings LLC	721	$74K	0.0%	-42.5%	0.002%
7/19/2023	Teacher Retirement System of Texas	6,531	$0.67M	0.0%	-21.4%	0.017%
7/18/2023	Allspring Global Investments Holdings LLC	721	$74K	0.0%	-42.5%	0.002%
7/14/2023	KRS Capital Management LLC	27,941	$2.85M	2.8%	-0.7%	0.074%
7/13/2023	Cambridge Investment Research Advisors Inc.	2,192	$0.22M	0.0%	N/A	0.006%
7/10/2023	SG Americas Securities LLC	4,761	$0.49M	0.0%	-44.4%	0.013%
7/6/2023	MADDEN SECURITIES Corp	21,000	$2.14M	1.1%	-11.4%	0.056%
7/3/2023	LBJ Family Wealth Advisors Ltd.	25,604	$2.61M	1.8%	-14.4%	0.068%
6/14/2023	State Board of Administration of Florida Retirement System	8,707	$0.79M	0.0%	-2.5%	0.023%
5/16/2023	First Light Asset Management LLC	1,586,928	$144.28M	13.0%	-23.1%	4.321%
5/16/2023	Altium Capital Management LP	35,000	$3.18M	1.8%	N/A	0.095%
5/16/2023	Bridger Management LLC	24,800	$2.26M	0.8%	N/A	0.068%
5/15/2023	Suvretta Capital Management LLC	15,100	$1.37M	0.1%	N/A	0.041%
5/15/2023	Moore Capital Management LP	58,301	$5.30M	0.1%	N/A	0.159%
5/15/2023	Solidarity Wealth LLC	6,866	$0.62M	0.3%	N/A	0.019%
5/15/2023	Farallon Capital Management LLC	325,000	$29.55M	0.2%	-2.1%	0.885%
5/15/2023	HAP Trading LLC	10,319	$0.94M	0.1%	N/A	0.028%
5/12/2023	Sectoral Asset Management Inc.	25,000	$2.27M	0.4%	N/A	0.068%
5/12/2023	WINTON GROUP Ltd	10,882	$0.99M	0.1%	+20.7%	0.030%
5/12/2023	Wellington Management Group LLP	1,421,162	$129.21M	0.0%	-5.8%	3.870%
5/12/2023	Profund Advisors LLC	4,606	$0.42M	0.0%	N/A	0.013%
5/12/2023	HighTower Advisors LLC	48,978	$4.45M	0.0%	-6.5%	0.133%
5/10/2023	Credit Suisse AG	41,476	$3.77M	0.0%	+6.0%	0.113%
5/10/2023	Pictet Asset Management SA	3,204	$0.29M	0.0%	N/A	0.009%
5/10/2023	Swiss National Bank	58,200	$5.29M	0.0%	-10.2%	0.158%
5/10/2023	Tekla Capital Management LLC	17,850	$1.62M	0.1%	N/A	0.049%
5/10/2023	TimesSquare Capital Management LLC	3,400	$0.31M	0.0%	N/A	0.009%
5/9/2023	Biondo Investment Advisors LLC	3,550	$0.32M	0.1%	N/A	0.010%
5/9/2023	Bank of New York Mellon Corp	101,675	$9.24M	0.0%	-0.3%	0.277%
5/9/2023	Integral Health Asset Management LLC	71,000	$6.46M	1.3%	-16.5%	0.193%
5/9/2023	California State Teachers Retirement System	33,980	$3.09M	0.0%	-1.2%	0.093%
5/9/2023	US Bancorp DE	9,646	$0.88M	0.0%	+1,280.0%	0.026%
5/8/2023	Braun Stacey Associates Inc.	311,010	$28.28M	0.7%	N/A	0.847%
5/8/2023	Federated Hermes Inc.	16,697	$1.52M	0.0%	N/A	0.045%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	6,497	$0.59M	0.0%	+23.1%	0.018%
5/8/2023	Sigma Planning Corp	6,320	$0.58M	0.0%	-32.0%	0.017%
5/5/2023	Prime Capital Investment Advisors LLC	5,700	$0.52M	0.0%	N/A	0.016%
5/4/2023	Barclays PLC	16,756	$1.52M	0.0%	+5.6%	0.046%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	12,883	$1.17M	0.0%	+1.4%	0.035%
5/4/2023	Emerald Mutual Fund Advisers Trust	255,018	$23.19M	1.4%	-51.6%	0.694%
5/4/2023	Emerald Advisers LLC	314,621	$28.61M	1.4%	-53.7%	0.857%
5/3/2023	Integrated Wealth Concepts LLC	11,294	$1.03M	0.0%	N/A	0.031%
5/2/2023	Victory Capital Management Inc.	161,682	$14.70M	0.0%	N/A	0.440%
5/2/2023	Nisa Investment Advisors LLC	741	$67K	0.0%	+195.2%	0.002%
5/2/2023	Amalgamated Bank	3,754	$0.34M	0.0%	-11.9%	0.010%
4/28/2023	Ameritas Advisory Services LLC	3,908	$0.36M	0.0%	N/A	0.011%
4/28/2023	SG Americas Securities LLC	8,558	$0.78M	0.0%	+23.1%	0.023%

Data available starting January 2016

See Full Table

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated with connective tissue disease; omaveloxolone to treat Friedreich's ataxia; and conduct various form of CKD, such as, type 1 and type 2 diabetic CKD, type 1 and type 2 diabetic CKD, hypertensive CKD, focal segmental glomerulosclerosis, and others. It is also developing RTA 901 for neurological diseases; and bardoxolone for the treatment of autosomal dominant polycystic kidney disease. In addition, the company has a strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize bardoxolone for renal, cardiovascular, diabetes, and various other related metabolic indications in Japan, China, Hong Kong, Macao, South Korea, Taiwan, Thailand, Singapore, the Philippines, Malaysia, Indonesia, Brunei, Vietnam, Laos, Myanmar, and Cambodia; AbbVie Inc. to jointly research, develop, and commercialize all second- and later-generation Nrf2 activators for all indications other than renal, cardiovascular, and metabolic indications. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas.

Today's Range

Now: $172.36

$172.32

$172.46

50 Day Range

MA: $171.30

$168.70

$172.36

52 Week Range

Now: $172.36

$21.83

$172.46

Volume

1,988,500 shs

Average Volume

1,091,032 shs

Market Capitalization

$6.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

Who are the company insiders with the largest holdings of Reata Pharmaceuticals?: Reata Pharmaceuticals' top insider investors include:
Manmeet Singh Soni (CFO)
Michael D Wortley (Insider)
Dawn Carter Bir (Insider)
Andrea Loewen (SVP)
Bhaskar Anand (CAO)
Shamim Ruff (Director)
Learn More about top insider investors at Reata Pharmaceuticals.